Skip to main content
. 2013 Aug 23;13:394. doi: 10.1186/1471-2407-13-394

Table 2.

Clinicopathological characteristics of GC according to presence of metachronous MPC

 
No MPC
Meta MPC
Pvalue
  (n= 2996) (n= 38)  
Sex
 
 
 
  Male
2010 (67.1%)
32 (84.2%)
0.025
  Female
986 (32.9%)
6 (15.8%)
 
Age
57.2 ± 11.8
63.6 ± 7.7
<0.001
Stage
 
 
 
  I
1598 (53.3%)
26 (68.4%)
0.011
  II
430 (14.4%)
9 (23.7%)
 
  III
726 (24.2%)
3 (7.9%)
 
  IV
242 (8.1%)
0 (0%)
 
Multiplicity
 
 
 
  Single
2802 (93.5%)
29 (76.3%)
<0.001
  ≥2
194 (6.5%)
9 (23.7%)
 
Location
 
 
 
  Upper
1481 (50.4%)
19 (52.8%)
0.709
  Mid
1003 (34.1%)
10 (27.8%)
 
  Lower
339 (11.5%)
6 (16.7%)
 
  Diffuse
115 (3.9%)
1 (2.8%)
 
Cell type
 
 
 
  Tubular
2334 (77.9%)
32 (84.2%)
0.703
  Signet ring cell
503 (16.8%)
5 (13.2%)
 
  Mucinous
72 (2.4%)
0 (0%)
 
  Others
87 (2.9%)
1 (2.6%)
 
Maximal tumor size
4.1 ± 2.8
3.0 ± 1.8
<0.001
Initial CEA
4.6 ± 21.5
3.4 ± 4.1
0.763
Initial CA 19-9
40.1 ± 319.1
8.0 ± 6.9
0.662
Smoking History
 
 
 
  Current smoker
804 (27.2%)
14 (36.8%)
0.402
  Ex-smoker
406 (13.7%)
4 (10.5%)
 
  Never-smoker
1746 (59.1%)
20 (52.6%)
 
Alcoholic History
 
 
 
  Current drinker
1235 (41.8%)
22 (57.9%)
0.048
  Ex-drinker
196 (6.6%)
4 (10.5%)
 
  Never-drinker
1521 (51.5%)
12 (31.6%)
 
Outcome
 
 
 
  Alive
2290 (76.4%)
13 (34.2%)
 
  Dead 706 (23.6%) 25 (65.8%)